查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1370920

靜脈水合治療市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按服務、按組件、按最終用途行業、按地區、競爭細分

Intravenous Hydration Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Service, By Component, By End-Use Industry, By Region, Competition
出版日期: | 出版商: TechSci Research | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年全球靜脈 (IV)水合治療市場價值為 30.4 億美元，預計在預測期內將出現顯著成長，預計年複合成長率 (CAGR) 為 6.76%，預計到 2028 年將達到 44.9 億美元.靜脈(IV)水合療法是一種醫療方法，涉及透過靜脈將液體、電解質（有時還包括藥物）直接輸送到人的血液中。這種療法通常用於解決脫水和各種醫療狀況。

主要市場促進因素

  • 1.手術數量的增加推動市場成長：全球靜脈（IV）水化治療市場的成長主要是由手術數量的增加所推動的。靜脈水化療法在手術介入之前、期間和之後為患者提供支持方面發揮著至關重要的作用。外科手術可能導致液體和電解質失衡，因此適當的水合和電解質管理對於成功的結果和患者的康復至關重要。靜脈水化療法可確保患者在手術前獲得充足的水分，支持穩定的血壓、最佳的器官功能和整體健康。在手術期間，靜脈補液療法有助於維持適當的水合水平和電解質平衡，並支持身體對手術壓力和麻醉的反應。手術後，靜脈水化療法對於預防併發症、促進癒合過程和降低術後問題的風險至關重要。
市場概況
預測期 2024-2028
2022 年市場規模 30.4億美元
2028 年市場規模 44.9億美元
2023-2028 年年複合成長率 6.76%
成長最快的細分市場 皮膚護理
最大的市場 北美洲
  • 2.健康和表現增強推動市場成長：以健康和生活方式為導向的方法的興起極大地促進了全球靜脈（IV）水化治療市場的成長。這一趨勢涉及個人尋求靜脈水化治療，不僅是出於醫療原因，而且是為了整體健康、改善生活方式和最佳化表現。靜脈水化療法被定位為滿足這些需求的解決方案。它提供了一種快速有效的方法來補充身體水分，這對於整體健康和最佳身體表現至關重要。運動員、健身愛好者和生活方式要求較高的個人採用靜脈補水療法來快速恢復水合水平、對抗疲勞並補充在劇烈體力活動中損失的必需電解質。對巔峰身體和認知表現的追求促使人們探索靜脈水化療法作為支持其目標的手段。根據個人需求量身定做的靜脈注射治療進一步吸引了那些尋求個人化解決方案以提高健康和表現的人。
  • 3.老化人口的成長推動市場成長：老化人口的成長是全球靜脈（IV）水化治療市場的重要驅動力。隨著年齡的成長，人們對脫水和電解質失衡的敏感度增加，使得靜脈補液療法成為重要的醫療干涉措施。老年人可能會感到口渴感減弱，導致液體攝取不足並增加脫水風險。靜脈水化療法可快速解決脫水問題，並有助於預防相關的健康併發症。隨著年齡的成長，包括腎臟疾病、糖尿病和心血管疾病在內的慢性疾病變得更加普遍，通常會導致體液和電解質失衡，需要定期靜脈補液治療來控制症狀和維持整體健康。老年人的醫療程序、手術和住院治療也更加頻繁，靜脈補液療法通常用於控制醫療干涉造成的液體和電解質失衡。此外，老年人經常服用多種可能影響液體和電解質平衡的藥物，這使得靜脈水化療法成為支持適當水化和最大限度減少藥物相關副作用的寶貴工具。

主要市場挑戰

  • 1.監管和法律考慮：監管和法律考慮對全球靜脈 (IV) 水化治療市場構成重大挑戰。確保患者安全、維持品質標準以及遵守當地和國際醫療實踐和醫療管理法規至關重要。進行靜脈水化治療的醫療保健提供者必須持有適當的許可證和認證，這可能涉及廣泛的培訓和教育。不同的司法管轄區有不同的要求，這可能會影響靜脈注射治療服務的可用性和可近性。
  • 2.公眾認知和教育：公眾認知和教育對全球靜脈（IV）水化治療市場提出了挑戰。對靜脈水化療法的適當醫學適應症的誤解和缺乏認知可能會阻礙其負責任的使用。靜脈水化治療的醫療必要性與健康或生活方式使用之間的區別可能不清楚，導致治療過度使用、使用不足或誤用。公眾的看法受到支持靜脈水化療法益處的科學證據的影響。對某些應用的臨床研究和實證研究不足可能會導致懷疑或不確定性。
  • 3.醫療專業知識：醫療專業知識是全球靜脈（IV）水化治療市場的重大挑戰。安全有效地管理靜脈輸液和營養物質需要專門的訓練和技能。接受過靜脈注射治療培訓的合格醫療保健從業人員的可用性可能會影響靜脈注射水化治療服務的可及性和品質。不同的醫療保健專業人士對靜脈注射療法的實踐範圍和法規各不相同，這可能會限制患者接受這些治療。複雜的患者病例可能需要更高程度的專業知識來確定適當的靜脈注射治療方案。

主要市場趨勢

  • 1.健康和生活方式使用的興起：全球靜脈 (IV)水合治療市場的一個顯著趨勢是以健康和生活方式為導向的使用的興起。這一趨勢表明，人們尋求靜脈注射補水療法不僅是出於醫療原因，也是為了整體健康、改善生活方式和最佳化表現。靜脈水化療法被認為是維持整體健康的補充方法，符合人們對整體健康日益成長的興趣。消費者，包括運動員和生活方式要求較高的消費者，紛紛透過靜脈補水療法來提高能量水平、消除疲勞並增強整體活力。靜脈水化療法提供的便利性和快速結果吸引了尋求立即恢復活力的忙碌人士。
  • 2.可客製化的治療：靜脈水化療法提供者擴大提供根據個人需求和目標量身定做的可客製化治療。這種個人化的方法允許患者根據具體要求調整液體和營養素的成分。可自訂的靜脈注射治療選項符合個人尋求健康、性能增強和整體福祉的客製化解決方案的趨勢。患者可以與醫療保健專業人員合作設計靜脈注射療法，以滿足他們獨特的健康和生活方式目標。

細分市場洞察

服務洞察： 2022 年，靜脈 (IV)水合治療市場以能量增強治療為主，預計這一趨勢將持續下去。這些治療可以立即解決疲勞、精力不足和活力不足的問題。運動員和生活方式忙碌的個人轉向能量增強靜脈注射療法，以提高他們的表現並快速補充必需的營養。對促進整體健康和改善生活方式的治療的需求支持了能量增強靜脈注射療法的成長，預計該細分市場從 2023 年到 2030 年將經歷最高的年複合成長率(CAGR)。

成分洞察： 2022 年，靜脈 (IV)水合治療市場由藥物細分市場主導，預計將繼續擴大。藥物靜脈水化療法通常用於需要針對性介入的醫療狀況。嚴重脫水、電解質失衡、營養缺乏或特定急性疾病的患者可受益於定製藥物的靜脈注射治療

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球靜脈 (IV)水合治療市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依服務分類（免疫增強劑、能量增強劑、皮膚護理、偏頭痛、其他）
    • 按成分（藥物、非藥物）
    • 按最終用途行業（醫院和診所、健康中心和水療中心、家庭保健、其他）
    • 按公司分類 (2022)
    • 按地區
  • 市場地圖

第 6 章：北美靜脈 (IV)水合治療市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按服務
    • 按組件
    • 按最終用途行業
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第 7 章：歐洲靜脈 (IV)水合治療市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按服務
    • 按組件
    • 按最終用途行業
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區靜脈 (IV)水合治療市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按服務
    • 按組件
    • 按最終用途行業
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第 9 章：南美洲靜脈 (IV)水合治療市場前景

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按服務
    • 按組件
    • 按最終用途行業
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲靜脈 (IV)水合治療市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按服務
    • 按組件
    • 按最終用途行業
    • 按國家/地區
  • MEA：國家分析
    • 南非 靜脈 (IV)水合療法
    • 沙烏地阿拉伯 靜脈 (IV)水合療法
    • 阿拉伯聯合大公國靜脈 (IV)水合療法

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 最近的發展
  • 產品發布
  • 併購

第 13 章：大環境分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 公司概況
  • 產品與服務
  • 財務（上市公司）
  • 最近的發展
  • SWOT分析
    • Core IV Therapy, LLC
    • Cryojuvenate UK Ltd.
    • B. Braun Medical Inc.
    • Otsuka Pharmaceutical Co., Ltd.
    • NexGen Health Inc
    • JW Life Science Corporation
    • Amanta Healthcare Ltd
    • Baxter International Inc.
    • Drip Hydration Inc

第 16 章：策略建議

簡介目錄
Product Code: 17102

The Global Intravenous (IV) Hydration Therapy Market, valued at USD 3.04 Billion in 2022, is poised for remarkable growth in the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 6.76% and expected to reach USD 4.49 Billion by 2028. Intravenous (IV) Hydration Therapy is a medical treatment involving the direct delivery of fluids, electrolytes, and sometimes medications into a person's bloodstream through a vein. This therapy is commonly utilized to address dehydration and various medical conditions.

Key Market Drivers

  • 1. Increasing Surgical Procedures Drive Market Growth: The growth of the global Intravenous (IV) hydration therapy market is primarily driven by the increasing number of surgical procedures. IV hydration therapy plays a vital role in supporting patients before, during, and after surgical interventions. Surgical procedures can lead to fluid and electrolyte imbalances, making proper hydration and electrolyte management crucial for successful outcomes and patient recovery. IV hydration therapy ensures that patients are adequately hydrated before surgery, supporting stable blood pressure, optimal organ function, and overall well-being. During surgery, IV hydration therapy helps maintain appropriate hydration levels and electrolyte balance, supporting the body's response to surgical stress and anesthesia. After surgery, IV hydration therapy is essential for preventing complications, facilitating the healing process, and reducing the risk of postoperative issues.
Market Overview
Forecast Period2024-2028
Market Size 2022USD 3.04 Billion
Market Size 2028USD 4.49 Billion
CAGR 2023-20286.76%
Fastest Growing SegmentSkin Care
Largest MarketNorth America
  • 2. Wellness and Performance Enhancement Drive Market Growth: The rise of wellness and lifestyle-oriented approaches has significantly contributed to the growth of the global Intravenous (IV) hydration therapy market. This trend involves individuals seeking IV hydration therapy not only for medical reasons but also for general wellness, lifestyle enhancement, and performance optimization. IV hydration therapy is positioned as a solution to address these needs. It offers a quick and efficient method to rehydrate the body, which is essential for overall well-being and optimal physical performance. Athletes, fitness enthusiasts, and individuals with demanding lifestyles turn to IV hydration therapy to rapidly restore hydration levels, combat fatigue, and replenish essential electrolytes lost during strenuous physical activity. The pursuit of peak physical and cognitive performance has led individuals to explore IV hydration therapy as a means to support their goals. Customizable IV treatments tailored to individual needs further appeal to those seeking personalized solutions for wellness and performance enhancement.
  • 3. Growing Aging Population Propels Market Growth: The increasing aging population is a significant driver of the global Intravenous (IV) hydration therapy market. As people age, their susceptibility to dehydration and electrolyte imbalances rises, making IV hydration therapy an essential medical intervention. Older adults may experience reduced thirst sensation, leading to inadequate fluid intake and an increased risk of dehydration. IV hydration therapy quickly addresses dehydration and helps prevent associated health complications. Chronic conditions, including kidney disease, diabetes, and cardiovascular disorders, become more prevalent with age, often leading to fluid and electrolyte imbalances that require regular IV hydration therapy for symptom management and overall health maintenance. Medical procedures, surgeries, and hospitalizations are also more frequent among older adults, with IV hydration therapy commonly used to manage fluid and electrolyte imbalances resulting from medical interventions. Additionally, older adults frequently take multiple medications that can affect fluid and electrolyte balance, making IV hydration therapy a valuable tool in supporting proper hydration and minimizing medication-related side effects.

Key Market Challenges

  • 1. Regulatory and Legal Considerations: Regulatory and legal considerations pose significant challenges to the global Intravenous (IV) hydration therapy market. Ensuring patient safety, maintaining quality standards, and adhering to local and international regulations governing medical practices and the administration of medical treatments are essential. Healthcare providers who administer IV hydration therapy must hold the appropriate licenses and certifications, which can involve extensive training and education. Different jurisdictions have varying requirements, which can affect the availability and accessibility of IV therapy services.
  • 2. Public Perception and Education: Public perception and education present challenges to the global Intravenous (IV) hydration therapy market. Misconceptions and lack of awareness about the appropriate medical indications for IV hydration therapy can hinder its responsible use. The distinction between medical necessity and wellness or lifestyle use of IV hydration therapy can be unclear, leading to overuse, underuse, or misuse of the treatment. Public perception is influenced by the availability of scientific evidence supporting the benefits of IV hydration therapy. Insufficient clinical studies and evidence-based research on certain applications can lead to skepticism or uncertainty.
  • 3. Medical Professional Expertise: Medical professional expertise is a significant challenge to the global Intravenous (IV) hydration therapy market. Administering IV fluids and nutrients safely and effectively requires specialized training and skills. The availability of qualified healthcare practitioners trained in IV therapy can impact the accessibility and quality of IV hydration therapy services. Different healthcare professions have varying scopes of practice and regulations regarding IV therapies, potentially restricting patient access to these treatments. Complex patient cases may require a higher level of expertise to determine appropriate IV therapy protocols.

Key Market Trends

  • 1. Rise of Wellness and Lifestyle Use: A notable trend in the global Intravenous (IV) Hydration Therapy market is the rise of wellness and lifestyle-oriented use. This trend sees individuals seeking IV hydration therapy not only for medical reasons but also for general wellness, lifestyle enhancement, and performance optimization. IV hydration therapy is perceived as a complementary approach to maintaining overall health, aligning with the growing interest in holistic well-being. Consumers, including athletes and those with demanding lifestyles, turn to IV hydration therapy to boost energy levels, recover from fatigue, and enhance overall vitality. The convenience and rapid results offered by IV hydration therapy appeal to busy individuals seeking immediate revitalization.
  • 2. Customizable Treatments: IV hydration therapy providers are increasingly offering customizable treatments tailored to individual needs and goals. This personalized approach allows patients to adjust the composition of fluids and nutrients based on specific requirements. Customizable IV therapy options align with the trend of individuals seeking tailored solutions for wellness, performance enhancement, and overall well-being. Patients can work with healthcare professionals to design IV treatments that address their unique health and lifestyle objectives.

Segmental Insights

Service Insights: In 2022, the Intravenous (IV) Hydration Therapy market was dominated by energy-boosting treatments, a trend predicted to continue. These treatments provide immediate solutions for fatigue, low energy levels, and vitality. Athletes and individuals with busy lifestyles turn to energy-boosting IV therapy to enhance their performance and quickly replenish essential nutrients. The demand for treatments that promote overall well-being and lifestyle enhancement supports the growth of energy-boosting IV therapy, with the segment projected to experience the highest compound annual growth rate (CAGR) from 2023 to 2030.

Component Insight: In 2022, the Intravenous (IV) Hydration Therapy market was dominated by the medicated segment, expected to continue expanding. Medicated IV hydration therapy is often employed for medical conditions requiring targeted interventions. Patients with severe dehydration, electrolyte imbalances, nutrient deficiencies, or specific acute illnesses benefit from IV therapy with tailored medications

and nutrients. Hospitals and clinical settings commonly use medicated IV therapy as part of standard medical protocols.

End-Use Industry Insights: In 2022, hospitals and clinics dominated the Intravenous (IV) Hydration Therapy market, expected to continue expanding. These healthcare settings provide a controlled and medically supervised environment for IV hydration therapy. Medical professionals, including doctors and nurses, are trained to assess patient needs and administer IV therapy safely. Hospitals and clinics offer comprehensive medical care, allowing IV hydration therapy to be integrated into overall patient treatment plans.

Regional Insights: The Asia Pacific region leads the Global Intravenous (IV) Hydration Therapy Market, with North America, particularly the United States and Canada, also playing a significant role. North America benefits from an advanced healthcare system, well-established healthcare facilities, and a health-conscious population. The prevalence of wellness trends and the pursuit of holistic health and performance optimization contribute to the popularity of IV therapy in this region.

Key Market Players

  • Core IV Therapy, LLC
  • Rejuvenated UK Ltd.
  • B. Braun Medical Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • NexGen Health Inc
  • JW Life Science Corporation
  • Amanta Healthcare Ltd
  • Baxter International Inc.
  • Drip Hydration Inc

Report Scope:

In this report, the Global Intravenous (IV) Hydration Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intravenous (IV) Hydration Therapy Market, By Service:

  • Immune Boosters
  • Energy Boosters
  • Skin Care
  • Migraine
  • Others

Intravenous (IV) Hydration Therapy Market, By Component:

  • Medicated
  • Non-medicated

Intravenous (IV) Hydration Therapy Market, By End-User:

  • Hospitals & Clinics
  • Wellness Centers & Spas
  • Home Healthcare
  • Others

Global Intravenous (IV) Hydration Therapy Market, By region:

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Intravenous (IV) Hydration Therapy Market.

Available Customizations:

  • Global Intravenous (IV) Hydration Therapy Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intravenous (IV) Hydration Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Immune Boosters, Energy Boosters, Skin Care, Migraine, Others)
    • 5.2.2. By Component (Medicated, Non-medicated)
    • 5.2.3. By End-Use Industry (Hospitals & Clinics, Wellness Centers & Spas, Home Healthcare, Others)
    • 5.2.4. By Company (2022)
    • 5.2.5. By Region
  • 5.3. Market Map

6. North America Intravenous (IV) Hydration Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Component
    • 6.2.3. By End-Use Industry
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Intravenous (IV) Hydration Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Component
        • 6.3.1.2.3. By End-Use Industry
    • 6.3.2. Mexico Intravenous (IV) Hydration Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Component
        • 6.3.2.2.3. By End-Use Industry
    • 6.3.3. Canada Intravenous (IV) Hydration Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Component
        • 6.3.3.2.3. By End-Use Industry

7. Europe Intravenous (IV) Hydration Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Component
    • 7.2.3. By End-Use Industry
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Intravenous (IV) Hydration Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Component
        • 7.3.1.2.3. By End-Use Industry
    • 7.3.2. Germany Intravenous (IV) Hydration Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Component
        • 7.3.2.2.3. By End-Use Industry
    • 7.3.3. United Kingdom Intravenous (IV) Hydration Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Component
        • 7.3.3.2.3. By End-Use Industry
    • 7.3.4. Italy Intravenous (IV) Hydration Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Component
        • 7.3.4.2.3. By End-Use Industry
    • 7.3.5. Spain Intravenous (IV) Hydration Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Component
        • 7.3.5.2.3. By End-Use Industry

8. Asia-Pacific Intravenous (IV) Hydration Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Component
    • 8.2.3. By End-Use Industry
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Intravenous (IV) Hydration Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Component
        • 8.3.1.2.3. By End-Use Industry
    • 8.3.2. India Intravenous (IV) Hydration Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Component
        • 8.3.2.2.3. By End-Use Industry
    • 8.3.3. South Korea Intravenous (IV) Hydration Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Component
        • 8.3.3.2.3. By End-Use Industry
    • 8.3.4. Japan Intravenous (IV) Hydration Therapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Component
        • 8.3.4.2.3. By End-Use Industry
    • 8.3.5. Australia Intravenous (IV) Hydration Therapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Component
        • 8.3.5.2.3. By End-Use Industry

9. South America Intravenous (IV) Hydration Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Component
    • 9.2.3. By End-Use Industry
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Intravenous (IV) Hydration Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Component
        • 9.3.1.2.3. By End-Use Industry
    • 9.3.2. Argentina Intravenous (IV) Hydration Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Component
        • 9.3.2.2.3. By End-Use Industry
    • 9.3.3. Colombia Intravenous (IV) Hydration Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Component
        • 9.3.3.2.3. By End-Use Industry

10. Middle East and Africa Intravenous (IV) Hydration Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service
    • 10.2.2. By Component
    • 10.2.3. By End-Use Industry
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Intravenous (IV) Hydration Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Component
        • 10.3.1.2.3. By End-Use Industry
    • 10.3.2. Saudi Arabia Intravenous (IV) Hydration Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Component
        • 10.3.2.2.3. By End-Use Industry
    • 10.3.3. UAE Intravenous (IV) Hydration Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Component
        • 10.3.3.2.3. By End-Use Industry

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Company Snapshot
  • 15.3. Products & Services
  • 15.4. Financials (In case of listed companies)
  • 15.5. Recent Developments
  • 15.6. SWOT Analysis
    • 15.6.1. Core IV Therapy, LLC
    • 15.6.2. Cryojuvenate UK Ltd.
    • 15.6.3. B. Braun Medical Inc.
    • 15.6.4. Otsuka Pharmaceutical Co., Ltd.
    • 15.6.5. NexGen Health Inc
    • 15.6.6. JW Life Science Corporation
    • 15.6.7. Amanta Healthcare Ltd
    • 15.6.8. Baxter International Inc.
    • 15.6.9. Drip Hydration Inc

16. Strategic Recommendations